Fenwick & West represented DexCom in the offering, while Davis Polk advised the representatives of several initial purchasers. DexCom, Inc. (Nasdaq: DXCM) priced its offering of $1.05 billion aggregate principal…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
